Finance

Lists
XBRANE:STO
Xbrane Biopharma AB
11,40 SEK
+1,79%
(+0,20) 1D
16 հոկ, 17:29:49 GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for XBRANE...
Open
11,10 SEK
High
11,55 SEK
Low
11,00 SEK
Mkt. cap
234,90 մլն
Avg. vol.
50,09 հզր
Volume
0,00
52-wk high
29,00 SEK
52-wk low
5,42 SEK
EPS
-3,64 SEK
Shares outstanding
20,61 մլն
No. of employees
29
Open
11,10 SEK
High
11,55 SEK
Low
11,00 SEK
Mkt. cap
234,90 մլն
Avg. vol.
50,09 հզր
Volume
0,00
52-wk high
29,00 SEK
52-wk low
5,42 SEK
EPS
-3,64 SEK
Shares outstanding
20,61 մլն
No. of employees
29
News stories
From web sources and news partners
About Xbrane Biopharma AB
CEOMartin Åmark
Employees29
Founded2008
Headquarters-
Sector-
Websitexbrane.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
10,12 մլն
9,09 մլն
17,34 մլն
46,75 մլն
Cost of goods sold
15,10 մլն
7,41 մլն
10,51 մլն
38,67 մլն
Cost of revenue
15,10 մլն
7,41 մլն
10,51 մլն
38,67 մլն
Research and development expenses
9,84 մլն
58,87 մլն
9,95 մլն
10,10 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,95 մլն
6,58 մլն
7,57 մլն
6,99 մլն
Operating expense
19,67 մլն
23,26 մլն
15,86 մլն
10,88 մլն
Total operating expenses
34,78 մլն
30,66 մլն
26,37 մլն
49,55 մլն
Operating income
-24,66 մլն
-21,58 մլն
-9,03 մլն
-2,80 մլն
Other non operating income
-1,00 հզր
-4,36 մլն
-
1,00 հզր
EBT including unusual items
-23,73 մլն
-26,20 մլն
-12,70 մլն
-11,28 մլն
EBT excluding unusual items
-23,73 մլն
-26,20 մլն
-12,70 մլն
-5,58 մլն
Income tax expense
6,00 հզր
-
89,00 հզր
-
Effective tax rate
-0,03%
-
-0,70%
-
Other operating expenses
1,88 մլն
-42,19 մլն
-1,66 մլն
-6,21 մլն
Net income
-24,03 մլն
-26,48 մլն
-13,07 մլն
-11,42 մլն
Net profit margin
-237,47%
-291,41%
-75,40%
-24,42%
Earnings per share
-1,17
-1,27
-
-
Interest and investment income
-
2,82 մլն
-
-
Interest expense
-196,00 հզր
-
-2,19 մլն
-2,28 մլն
Net interest expenses
-196,00 հզր
2,82 մլն
-2,19 մլն
-2,28 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,87 մլն
-16,01 մլն
-6,28 մլն
-67,00 հզր
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps